Find Clinical Trials & Studies

PROMISE III Study for Chronic Limb-Threatening Ischemia

I'm Interested!

Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Device
  • Trial Phase: NA
  • Conditions Being Studied: Critical Limb Ischemia (CLI)

Study Purpose

The purpose of this clinical study is to evaluate a device designed to create a connection between the artery and vein in the Below The Knee (BTK) vascular system using a minimally invasive approach.

Who Can Participate

Age: 18-98

Principal Investigator
Mehdi Shishehbor DO MPH PhD
Department/Division
Heart and Vascular (General Cardiology)

Locations

UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106

  • UH IRB: SITE00001769
  • StudyID: 2022-0952
  • ClinicalTrials.gov: NCT05313165
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422